纳米抗体特性及其在冠状病毒研究中的应用
摘要:
纳米抗体分子量小、结构稳定、溶解度高、易于编辑、组织穿透性强等,已经成为开发复杂纳米生物技术的理想研
究工具,被应用于生物医学和生物技术领域,在监测分子、免疫成像、疾病治疗等方面有巨大的作用,在冠状病毒研究
领域能够用于抑制受体和冠状病毒刺突蛋白受体结合域的相互作用,成为治疗新型冠状病毒肺炎的潜在药物,同时也
作为一种检测工具,监测人体免疫情况。该文综述了纳米抗体的结构、功能特性及其在生物技术领域和冠状病毒领域
的研究进展,并对其在生物技术和临床方面的应用前景进行了展望。
作者:
邓文月#张维达#孙慧敏#于海波
组织:
天津大学生命科学学院
发表日期:
2023-02-28 (中科知库平台首次上架日期,不代表论文发表的时间)
分类:
技术
浏览:170
|下载:
请先登录|大小:859.6 KB
[1] Hamers - Casterman C,Atarhouch T,Muyldermans S,et al. Naturally occurring antibodies devoid of light chains[J]. Nature,1993,363( 6428) : 446 - 448.
[2] Muyldermans S,Atarhouch T,Saldanha J,et al. Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains[J]. Protein Engineering,1994,7( 9) : 1129 - 1135.
[3] Muyldermans S. Nanobodies: natural single - domain antibodies[J]. Annual Review of Biochemistry,2013,82( 1) : 775 - 797.
[4] Hassanzadeh - Ghassabeh G,Devoogdt N,De Pauw P,et al. Nanobodies and their potential applications[J]. Nanomedicine,2013,8( 6) : 1013 - 1026.
[5] Heeke G V,Allosery K,Brabandere V D,et al. NanobodiesⓇ as inhaled biotherapeutics for lung diseases[J]. Pharmacology & Therapeutics,2017,169: 47 - 56.
[6] Mitchell L S,Colwell L J. Comparative analysis of nanobody sequence and structure data[J]. Proteins,2018,86( 7) : 697 - 706.
[7] Wang Y Z,Fan Z,Lei S,et al. Nanobody - derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications[J]. Int J Nanomedicine,2016,11: 3287 - 3303.
[8] Harmsen M M,Ruuls R C,Nijman I J,et al. Llama heavy - chain V regions consist of at least four distinct subfamilies revealing novel sequence features[J]. Mol Immunol,2000,37( 10) : 579- 590.
[9] Maass D R,Sepulveda J,Pernthaner A,et al. Alpaca( Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies( VHHs) [J]. J Immunol Methods,2007,324( 1 - 2) : 13- 25.
[10] Siontorou C G. Nanobodies as novel agents for disease diagnosis and therapy[J]. International Journal of Nanomedicine,2013,8:4215 - 4227.